These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 27131827)

  • 1. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arctigenin Attenuates Learning and Memory Deficits through PI3k/Akt/GSK-3β Pathway Reducing Tau Hyperphosphorylation in Aβ-Induced AD Mice.
    Qi Y; Dou DQ; Jiang H; Zhang BB; Qin WY; Kang K; Zhang N; Jia D
    Planta Med; 2017 Jan; 83(1-02):51-56. PubMed ID: 27224270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
    Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
    Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
    Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
    Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
    J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
    Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
    Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
    J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seed of
    Sun Y; Wu A; Li X; Qin D; Jin B; Liu J; Tang Y; Wu J; Yu C
    Pharm Biol; 2020 Dec; 58(1):35-43. PubMed ID: 31881157
    [No Abstract]   [Full Text] [Related]  

  • 13. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
    Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
    Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.
    Chen S; Sun J; Zhao G; Guo A; Chen Y; Fu R; Deng Y
    Neurochem Res; 2017 Aug; 42(8):2326-2335. PubMed ID: 28382596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β.
    Qi L; Chen Z; Wang Y; Liu X; Liu X; Ke L; Zheng Z; Lin X; Zhou Y; Wu L; Liu L
    Am J Transl Res; 2017; 9(2):247-260. PubMed ID: 28337257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
    Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
    Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
    Wang YJ; Ren QG; Gong WG; Wu D; Tang X; Li XL; Wu FF; Bai F; Xu L; Zhang ZJ
    Oncotarget; 2016 Mar; 7(12):13328-39. PubMed ID: 26950279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.